Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sclerotherapy Versus Beta‐blockers for Primary Prophylaxis of Oesophageal Variceal Bleeding in Children and Adolescents With Chronic Liver Disease or Portal Vein Thrombosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/. Accessed 16 May 2024.
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/. Accessed May 16, 2024.
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/
Sclerotherapy Versus Beta‐blockers for Primary Prophylaxis of Oesophageal Variceal Bleeding in Children and Adolescents With Chronic Liver Disease or Portal Vein Thrombosis [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
ID - 438073
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438073/all/
DB - Evidence Central
DP - Unbound Medicine
ER -